Retinopathy and optic neuropathy are well-known, severe ocular complications in patients undergoing radiation therapy for brain, head, and neck cancer. However, little is known about the prevalence... Show moreRetinopathy and optic neuropathy are well-known, severe ocular complications in patients undergoing radiation therapy for brain, head, and neck cancer. However, little is known about the prevalence and dose-response relationship of retinopathy and optic neuropathy in these patients. More knowledge about the prevalence and dose-response relationship may contribute to developing a high-precision radiation therapy approach.Background: Patients with brain, head, and neck tumors experience a decline in their quality of life due to radiation retinopathy and optic neuropathy. Little is known about the dose-response relationship and patient characteristics. We aimed to systematically review the prevalence of radiation retinopathy and optic neuropathy. Method: The primary outcome was the pooled prevalence of radiation retinopathy and optic neuropathy. The secondary outcome included the effect of the total radiation dose prescribed for the tumor according to the patient's characteristics. Furthermore, we aimed to evaluate the radiation dose parameters for organs at risk of radiation retinopathy and optic neuropathy. Results: The pooled prevalence was 3.8%. No retinopathy was reported for the tumor's prescribed dose of 50 Gy than <50 Gy. We observed a higher prevalence rate for retinopathy (6.0%) than optic neuropathy (2.0%). Insufficient data on the dose for organs at risk were reported. Conclusion: The prevalence of radiation retinopathy was higher compared to optic neuropathy. This review emphasizes the need for future studies considering retinopathy and optic neuropathy as primary objective parameters. Show less
